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Conclusion: When developing new drugs against Mycobac-
terium tuberculosis, it is important to note that this bacteria has
a solid and chemically resistant cell wall. Therefore, anti-TB agents
are speciﬁc and do not act on other pathogenic bacteria, and vice
versa - the huge variety of available antibiotics does not affect
the mycobacteria. For all tested compounds there is no correla-
tion between their antimycobacterial activity and activity against
other microorganisms. This indicates that the action of all potent
derivatives ((+)-camphor and (-)-fenchones) are speciﬁc to the
Mycobacteriumtuberculosis.All of themare stable, non-toxic against
human cells and show antimycobacterial activity in the nanomolar
range being 60 times more active than ethambutol.These results
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Background: Tuberculosis is an infectious disease causedby the
bacillusMycobacterium tuberculosis. Mycobacteremia is a key event
in the pathogenesis of tuberculosis and development of extra-
pulmonary TB. Genotyping of M. tuberculosis isolates is useful for
surveying the dynamics of TB infection, identifying new outbreaks,
and preventing the disease. We attempted to estimate the preva-
lence of M. tuberculosis bacteremia and its genotypes.
Methods & Materials: Suspected cases of tuberculosis were
screened formycobacteremia by culturing 5ml of peripheral blood
sample in the MB/BacT® culture system (bioMérieux, France).
Flashed positive bottles were screened for M. tuberculosis using in-
house multiplex PCR and further screened for drug susceptibility.
All isolates were subjected to spoligotyping, 24 loci MIRU-VNTR,
TbD1+/1 and RD analysis. Genotyping analysiswas performed using
SIT-VIT web and MIRU-VNTRplus online tools.
Results: Blood culture was performed from 469 patients (306
extrapulmonary, 50 pulmonary and 113 disseminated TB cases).
Seventy seven (16.4%) of these blood cultures were positive by
MB/BacT®. Of the 77 isolates, 36 (11.7%) were patients had extra-
pulmonary TB, 34 (30%) disseminated TB, and 7 (14%) pulmonary
tuberculosis. Among the culture positives 67 (87%) were identiﬁed
as M. tuberculosis and 10 (13%) as mycobacteria other than tuber-
culosis using in-house multiplex PCR. Spoligotyping identiﬁed 65
isolates (97%) belong to 16 previously described Share Types, while
the remaining two isolates had unique/un-identiﬁed Share Types
patterns based upon SIT-VIT web. Among them ST26 (CAS1 DEL)
was more predominant (49.2%) followed by ST25 (CAS1 DEL)
(9.2%), ST1 (Beijing) (9.2%) andST19 (EAI2 MANILLA) (7.6%). Largest
number of clustering of isolateswas detected in Beijing (100%), CAS
(97.4%), and EAI (81.8%) by spoligotyping. TbD1 analysis showed
that majority of the isolates (83.5%) were modern lineages (TbD1¯)
and 11 (16.4%) isolates belong to ancient linage (TbD1+). All the
ancient lineage isolates belong to EAI lineage.
Conclusion: CAS lineage was predominantly found among
mycobacteremiapatients. This pattern is notdifferent fromthepre-
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Background: The problems with any PCR method using DNA
sequences as targets for ampliﬁcation include false-positive results,
the inability to detect a difference between viable and nonvi-
able organisms and the inability to determine drug susceptibility.
Instead of DNA detecting assays, using RT-qPCR to assess the
expression of the 85B mRNA gene of M. tuberculosis indicates the
presence of a viable organism. In this study, we used the mRNA
coding for 85B antigen complex which is present in all mycobac-
teria. We aimed to assess the diagnostic performance of RT-qPCR
method by comparing with the real-time PCR Cobas TaqMan MTB
kit.
Methods & Materials: A total of 54 cases including 32 (17
males, 15 females) patientswith conﬁrmed tuberculosis and 22 (13
males, 9 females) individualswithout tuberculosiswere includedas
patient and control groups, respectively. Themean ages of 30males
and 24 females were 37,06 ± 8,88 and 36,75 ± 8,96, respectively.
Decontamination with N-acetyl-L-cysteine and sodium hydrox-
ide (NALC–NaOH) at 2% and Mycobacterial Growth Indicator Tube
(MGIT) 960 system was used for the laboratory diagnosis of spu-
tum samples. Decontaminated samples were used for the manual
extraction of M. tuberculosis DNA and 85B mRNA. Extracted DNA
was used for Cobas TaqManMTBDNA qPCR kit (Roche Diagnostics)
in a cobas TaqMan 48 analyzer. For RT-qPCR method, total RNA
was extracted from the sputum specimen using standard TRIzol
protocol (Invitrogen) and 85B mRNA analyses were performed on
LightCycler 480 II system.
Results: A signiﬁcant difference was detected between patients
and control groups by RT-qPCR method (p<0.001) and Cobas Taq-
ManMTBDNA qPCR kit (p=0.0027). Sensitivity, speciﬁcity, positive
and negative predictive values and kappa coefﬁcient were deter-
mined as 97%, 95%, 97%, 95%, 0.89% for RT-qPCR method and 91%,
